News

Our colleague Ann Meulemans is attending the 2017 BIO International Convention, the global event for biotechnology, in San Diego, USA, from June 19-22th.

We are very proud to present our new website. From now on we have a nice landing page from which you can easily find everything you want on our website. Check it out en try it for yourself.

In what is becoming an annual tradition, 2 Bridge will again be present at the next edition of Knowledge for Growth, Europe’s finest life sciences conference, organized by FlandersBio in Ghent on Thursday, May 18th, 2017. We are looking forward to meet you there!

We are very excited to announce that 2 Bridge has welcomed 2 new enthusiastic team members:
Maarten Huisman (preclinical project director)
Lien Lybaert (scientific project manager)
We wish both of them good luck in their new job!

OCTIMET Oncology NV (OCTIMET) has secured EUR 11.3 million in a Series A investment round, enabling the company to accelerate the development of a clinically de-risked MET kinase inhibitor, as single agent or in combination with standard of care and targeted agents for the treatment of solid cancers.

Our colleagues Ann Meulemans and Geertje Van Beeck are attending the 11th edition of BIO-Europe Spring, the annual international life science partnering conference, in Barcelona, from March 20-22th, 2017.

The amount of new legislations and guidelines to control drug products in the last 2 years, has put a lot of strain on quality departments within pharmaceutical organizations.

Are you struggling to comply with these new guidelines? Let us help you….

2 Bridge has a team of people with the right experience to help you with both strategic and hands-on support to guide you to compliance with these recent guidelines.
We can offer senior staff or junior staff to support your every need on your way to compliance….

We are excited to announce that 2 Bridge has officially moved from its former office in Turnhout to a new address: Rodendijk 60X 2980 Zoersel Come visit us at our new location!

Our colleagues Ann Meulemans and Leen Thielemans are attending Europe’s largest partnering conference serving the global biotechnology industry, BIO-Europe 2016, in November, 2016.

2 Bridge and Inovigate are proud to announce a strategic collaboration to provide fully integrated solutions in healthcare product development. The combined strength of our services go from drug development strategy over due diligence and opportunity scouting to product development, strategy and business planning – Matching the Target Product Profile with the Target Market Profile.